R.A. Bojar

2.1k total citations
37 papers, 1.5k citations indexed

About

R.A. Bojar is a scholar working on Dermatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, R.A. Bojar has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Dermatology, 9 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in R.A. Bojar's work include Acne and Rosacea Treatments and Effects (19 papers), Dermatology and Skin Diseases (11 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). R.A. Bojar is often cited by papers focused on Acne and Rosacea Treatments and Effects (19 papers), Dermatology and Skin Diseases (11 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). R.A. Bojar collaborates with scholars based in United Kingdom, Austria and Japan. R.A. Bojar's co-authors include Keith T. Holland, K.T. Holland, W.J. Cunliffe, Eileen Ingham, C. E. JONES, E. Anne Eady, W.J. Cunliffe, D.B. Holland, Jonathan H. Cove and John P. Leeming and has published in prestigious journals such as Journal of Bacteriology, Journal of Investigative Dermatology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

R.A. Bojar

37 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.A. Bojar United Kingdom 23 962 246 245 213 159 37 1.5k
D.B. Holland United Kingdom 19 1.5k 1.5× 198 0.8× 384 1.6× 92 0.4× 68 0.4× 44 2.0k
Keith T. Holland United Kingdom 18 457 0.5× 174 0.7× 406 1.7× 38 0.2× 246 1.5× 24 1.1k
Otto H. Mills United States 22 1.3k 1.4× 238 1.0× 127 0.5× 87 0.4× 136 0.9× 53 1.6k
H.C. Korting Germany 19 626 0.7× 181 0.7× 182 0.7× 31 0.1× 81 0.5× 66 1.2k
Mi Young Yoon South Korea 26 343 0.4× 70 0.3× 456 1.9× 41 0.2× 118 0.7× 50 1.5k
Alexander Roeder Germany 7 299 0.3× 119 0.5× 171 0.7× 38 0.2× 111 0.7× 7 745
Setsuko Nishijima Japan 17 373 0.4× 144 0.6× 161 0.7× 43 0.2× 289 1.8× 51 806
Calvin T. Sung United States 20 317 0.3× 84 0.3× 615 2.5× 59 0.3× 60 0.4× 49 1.5k
C. Cătoi Romania 22 112 0.1× 165 0.7× 242 1.0× 141 0.7× 21 0.1× 115 1.1k
Fiorentina Ascenzioni Italy 24 96 0.1× 128 0.5× 690 2.8× 334 1.6× 91 0.6× 65 1.4k

Countries citing papers authored by R.A. Bojar

Since Specialization
Citations

This map shows the geographic impact of R.A. Bojar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.A. Bojar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.A. Bojar more than expected).

Fields of papers citing papers by R.A. Bojar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.A. Bojar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.A. Bojar. The network helps show where R.A. Bojar may publish in the future.

Co-authorship network of co-authors of R.A. Bojar

This figure shows the co-authorship network connecting the top 25 collaborators of R.A. Bojar. A scholar is included among the top collaborators of R.A. Bojar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.A. Bojar. R.A. Bojar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bojar, R.A.. (2015). Studying the Human Skin Microbiome Using 3D In Vitro Skin Models. 1(2). 165–171. 30 indexed citations
3.
Ooi, Nicola, I. Chopra, E. Anne Eady, et al.. (2013). Antibacterial activity and mode of action of tert-butylhydroquinone (TBHQ) and its oxidation product, tert-butylbenzoquinone (TBBQ). Journal of Antimicrobial Chemotherapy. 68(6). 1297–1304. 33 indexed citations
4.
Wilshaw, Stacy‐Paul, et al.. (2012). Assessment of the Antimicrobial Activity of Acellular Vascular Grafts. European Journal of Vascular and Endovascular Surgery. 43(5). 573–581. 7 indexed citations
5.
Gawkrodger, D.J., Gregory E. Harris, & R.A. Bojar. (2009). Chloracne in seven organic chemists exposed to novel polycyclic halogenated chemical compounds (triazoloquinoxalines). British Journal of Dermatology. 161(4). 939–943. 7 indexed citations
6.
Ingham, Eileen, et al.. (2008). In vitromodulation of human keratinocyte pro- and anti-inflammatory cytokine production by the capsule ofMalasseziaspecies. FEMS Immunology & Medical Microbiology. 54(2). 203–214. 49 indexed citations
7.
Holland, D.B., R.A. Bojar, Anthony H.T. Jeremy, Eileen Ingham, & Keith T. Holland. (2008). Microbial colonization of anin vitromodel of a tissue engineered human skin equivalent â a novel approach. FEMS Microbiology Letters. 279(1). 110–115. 60 indexed citations
8.
Yung, Anthony, G.I. Stables, Catherine Fernandez, et al.. (2007). Microbiological effect of photodynamic therapy (PDT) in healthy volunteers: a comparative study using methyl aminolaevulinate and hexyl aminolaevulinate cream. Clinical and Experimental Dermatology. 32(6). 716–721. 19 indexed citations
10.
Pollock, Bruce G., Duncan L. Turner, Mark R. Stringer, et al.. (2004). Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. British Journal of Dermatology. 151(3). 616–622. 173 indexed citations
11.
Bojar, R.A., et al.. (2004). The effect of lipids on the adherence of axillary aerobic coryneform bacteria. Letters in Applied Microbiology. 38(6). 470–475. 6 indexed citations
12.
Bojar, R.A. & Keith T. Holland. (2004). Acne and propionibacterium acnes. Clinics in Dermatology. 22(5). 375–379. 185 indexed citations
13.
Holland, Keith T. & R.A. Bojar. (2002). Cosmetics. American Journal of Clinical Dermatology. 3(7). 445–449. 77 indexed citations
14.
Layton, Alison, et al.. (1995). Staphylococcus lugdunensis isolated from axillary apocrine glands of hidradenitis suppurativa patients.. Journal of Investigative Dermatology. 4(104). 618. 1 indexed citations
15.
Bojar, R.A., Norbert Hittel, W.J. Cunliffe, & K.T. Holland. (1995). Direct Analysis of Resistance in the Cutaneous Microflora during Treatment of Acne Vulgaris with Topical 1% Nadifloxacin and 2% Erythromycin. Drugs. 49(Supplement 2). 164–167. 16 indexed citations
16.
Bojar, R.A., W.J. Cunliffe, & K.T. Holland. (1994). Disruption of the transmembrane pH gradient—a possible mechanism for the antibacterial action of azelaic acid in Propionibucterium acnes and Staphylococcus epidermidis. Journal of Antimicrobial Chemotherapy. 34(3). 321–330. 34 indexed citations
17.
Bojar, R.A., et al.. (1994). Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc. British Journal of Dermatology. 130(3). 329–336. 61 indexed citations
18.
Kearney, John N., R.A. Bojar, & K.T. Holland. (1993). Ethylene oxide sterilisation of allogenic bone implants. Clinical Materials. 12(3). 129–135. 22 indexed citations
19.
Bojar, R.A., et al.. (1993). Follicular concentrations of azelaic acid after a single topical application. British Journal of Dermatology. 129(4). 399–402. 25 indexed citations
20.
Bojar, R.A., Keith T. Holland, & W.J. Cunliffe. (1991). The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37. Journal of Antimicrobial Chemotherapy. 28(6). 843–853. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026